National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021
BACKGROUND Aligned with World Health Organization (WHO) goals, Ukraine aims to eliminate viral hepatitis. While some data on viral hepatitis B and C prevalence exist among key populations, nationwide prevalence in the general population has never been assessed. AIM To assess the prevalence of viral...
Saved in:
Main Author: | Olena Nesterova |
---|---|
Format: | Article |
Language: | English |
Published: |
European Centre for Disease Prevention and Control
2025-07-01
|
Series: | Eurosurveillance |
Subjects: | |
Online Access: | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.29.2500015 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatitis B vaccines in clinical practice /
Published: (1993) -
Virological and morphological relationships in the phases of the immune control and reactivation in patients with chronic hepatitis B
by: I. A. Gabdrakhmanov, et al.
Published: (2016-02-01) -
Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01) -
Human hepatitis B immunoglobulins: Standardisation issues
by: E. A. Konovalova, et al.
Published: (2025-06-01) -
Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)